Ketoacidosis

Ketoacidosis is a metabolic state in which acidic ketone bodies accumulate in the blood, lowering its pH and disrupting normal physiology. It develops when cells cannot use enough glucose for energy, prompting increased fat breakdown; the liver converts fatty acids into ketones, while inadequate insulin or another metabolic stressor limits glucose utilization and ketone clearance. Ketoacidosis is most strongly associated with uncontrolled diabetes, but it can also occur during prolonged fasting, heavy alcohol use, or other conditions that alter metabolism. Understanding its biochemical mechanism supports recognition, laboratory diagnosis, and treatment of a potentially life-threatening acid–base disturbance.

Ketoacidosis - Related Videos

Education

JoVE Core - Pathophysiology

Diabetic Ketoacidosis ll: Pathophysiology

0 Views •

2026

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...

Diabetic Ketoacidosis l: Introduction

0 Views •

2026

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...

Research

JoVE Journal - Medicine
Free Sample

Improving IV Insulin Administration in a Community Hospital

0 Views •

Cited by 7 •

2012

When compared to the previous paper protocol, implementation of a computerized glucose management system results in a substantial increase in blood glucose concentration measurements within the target range. Using a computerized glucose management system to monitor blood glucose levels, decreases in severe hypoglycemia (<40 mg/dL), clinical hypoglycemia (<70 mg/dL), and hyperglycemia (>180 mg/dL) also can be observed.

View All Results

FAQs

Related Topics